Valuation : Boule Diagnostics AB

Market Cap 119M 12.39M 10.69M 10.05M 9.16M 17.22M 1.18B 17.31M 46.25M 598M 46.51M 45.5M 1.98B P/E 2026 *
-12.2x
P/E 2027 * 13.8x
Enterprise Value 315M 32.88M 28.36M 26.68M 24.3M 45.7M 3.12B 45.95M 123M 1.59B 123M 121M 5.26B EV / Sales 2026 *
0.7x
EV / Sales 2027 * 0.63x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day+0.33%
1 week-1.92%
Current month-1.92%
1 month-19.21%
3 months-5.25%
6 months-24.38%
Current year-37.47%
1 week 3.06
Extreme 3.06
3.28
1 month 3.06
Extreme 3.06
3.91
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.64
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
59.5
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/23 A Buy

Chief Financial Officer

8,000 0.0206%
2/6/23 A Buy

Director

7,083 0.0182%
2/17/22 A Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-1.92%-48.83%-68.99% 12.39M
-2.69%-4.40%+21.87%+7.77% 222B
-3.10%-4.19%+0.54%-22.09% 145B
-2.02%-0.70%-21.98%+18.96% 130B
-0.46%-3.57%-54.43%-10.33% 69.68B
-0.01%-0.14%+11.56%+18.80% 52.3B
-0.74%-0.56%-15.61%-14.33% 50.71B
-2.36%-3.13%+19.31%+22.98% 42.28B
-2.12%-2.08%+34.47%+44.42% 39.87B
-3.64%-2.21%-15.72%+45.34% 33.37B
Average -1.38%-1.52%-6.88%+4.25% 78.62B
Weighted average by Cap. -1.66%-1.58%-0.31%+6.07%

Financials

2026 *2027 *
Net sales 453M 47.24M 40.75M 38.33M 34.92M 65.66M 4.48B 66.02M 176M 2.28B 177M 174M 7.56B 483M 50.39M 43.46M 40.88M 37.25M 70.04M 4.78B 70.42M 188M 2.43B 189M 185M 8.07B
Net income -9.77M -1.02M -879K -827K -753K -1.42M -96.7M -1.42M -3.8M -49.19M -3.83M -3.74M -163M 8.6M 896K 773K 727K 662K 1.25M 85.05M 1.25M 3.35M 43.26M 3.36M 3.29M 143M
Net Debt 197M 20.49M 17.67M 16.63M 15.15M 28.48M 1.94B 28.64M 76.5M 989M 76.93M 75.26M 3.28B 185M 19.24M 16.59M 15.61M 14.22M 26.74M 1.83B 26.88M 71.82M 929M 72.22M 70.65M 3.08B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
02/09/26 SEK 3.070 +0.33% 252
01/09/26 SEK 3.060 -2.24% 18,555
31/08/26 SEK 3.130 -1.26% 38,909
28/08/26 SEK 3.170 +1.60% 32,422
27/08/26 SEK 3.120 -0.32% 27,493
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.060SEK
Average target price
3.800SEK
Spread / Average Target
+24.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock